Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = photosensitive drug-induced cutaneous eruption

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
17 pages, 9692 KiB  
Review
Latest Evidence Regarding the Effects of Photosensitive Drugs on the Skin: Pathogenetic Mechanisms and Clinical Manifestations
by Flavia Lozzi, Cosimo Di Raimondo, Caterina Lanna, Laura Diluvio, Sara Mazzilli, Virginia Garofalo, Emi Dika, Elena Dellambra, Filadelfo Coniglione, Luca Bianchi and Elena Campione
Pharmaceutics 2020, 12(11), 1104; https://doi.org/10.3390/pharmaceutics12111104 - 17 Nov 2020
Cited by 26 | Viewed by 8940
Abstract
Photosensitivity induced by drugs is a widely experienced problem, concerning both molecule design and clinical practice. Indeed, photo-induced cutaneous eruptions represent one of the most common drug adverse events and are frequently an important issue to consider in the therapeutic management of patients. [...] Read more.
Photosensitivity induced by drugs is a widely experienced problem, concerning both molecule design and clinical practice. Indeed, photo-induced cutaneous eruptions represent one of the most common drug adverse events and are frequently an important issue to consider in the therapeutic management of patients. Phototoxicity and photoallergy are the two different pathogenic mechanisms involved in photosensitization. Related cutaneous manifestations are heterogeneous, depending on the culprit drug and subject susceptibility. Here we report an updated review of the literature with respect to pathogenic mechanisms of photosensitivity, clinical manifestations, patient management, and prediction and evaluation of drug-induced photosensitivity. We present and discuss principal groups of photosensitizing drugs (antimicrobials, nonsteroidal anti-inflammatory drugs, anti-hypertensives, anti-arrhythmics, cholesterol, and glycemia-lowering agents, psychotropic drugs, chemotherapeutics, etc.) and their main damage mechanisms according to recent evidence. The link between the drug and the cutaneous manifestation is not always clear; more investigations would be helpful to better predict drug photosensitizing potential, prevent and manage cutaneous adverse events and find the most appropriate alternative therapeutic strategy. Full article
(This article belongs to the Special Issue Formulation of Photosensitive Drugs)
Show Figures

Figure 1

Back to TopTop